176 related articles for article (PubMed ID: 20183447)
21. Mantel-Haenszel-type inference for cumulative odds ratios with a stratified ordinal response.
Liu IM; Agresti A
Biometrics; 1996 Dec; 52(4):1223-34. PubMed ID: 8962452
[TBL] [Abstract][Full Text] [Related]
22. [Introduction to the statistical aspects of planning clinical oncologic phase III studies].
Sylvester R; Minder CE
Urologe A; 1995 Sep; 34(5):367-73. PubMed ID: 7483152
[TBL] [Abstract][Full Text] [Related]
23. An adaptive group sequential design for phase II/III clinical trials that select a single treatment from several.
Kelly PJ; Stallard N; Todd S
J Biopharm Stat; 2005; 15(4):641-58. PubMed ID: 16022169
[TBL] [Abstract][Full Text] [Related]
24. Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients.
Freidlin B; Simon R
Clin Cancer Res; 2005 Nov; 11(21):7872-8. PubMed ID: 16278411
[TBL] [Abstract][Full Text] [Related]
25. Adaptive designs for confirmatory clinical trials.
Bretz F; Koenig F; Brannath W; Glimm E; Posch M
Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
[TBL] [Abstract][Full Text] [Related]
26. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
Merlo-Pich E; Alexander RC; Fava M; Gomeni R
Clin Pharmacol Ther; 2010 Nov; 88(5):634-42. PubMed ID: 20861834
[TBL] [Abstract][Full Text] [Related]
27. Treatment of depression--newer pharmacotherapies.
Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
[TBL] [Abstract][Full Text] [Related]
28. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
Roy A; Bhaumik DK; Aryal S; Gibbons RD
Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
[TBL] [Abstract][Full Text] [Related]
29. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
Brutti P; De Santis F; Gubbiotti S
Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
[TBL] [Abstract][Full Text] [Related]
30. Paradigms for adaptive statistical information designs: practical experiences and strategies.
Wang SJ; Hung HM; O'Neill R
Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
[TBL] [Abstract][Full Text] [Related]
31. Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2011 Jan; 21(1):94-110. PubMed ID: 21191857
[TBL] [Abstract][Full Text] [Related]
32. Perils of evidence-based medicine.
Williams BA
Perspect Biol Med; 2010; 53(1):106-20. PubMed ID: 20173299
[TBL] [Abstract][Full Text] [Related]
33. Seamless Phase II/III combination study through response adaptive randomization.
Wang L; Cui L
J Biopharm Stat; 2007; 17(6):1177-87. PubMed ID: 18027224
[TBL] [Abstract][Full Text] [Related]
34. Design of adaptive two-stage double-arm clinical trials for dichotomous variables.
Jiang Z; Xue F; Li C; Wang L; Cai H; Zhang C; Xia J
Contemp Clin Trials; 2010 May; 31(3):242-50. PubMed ID: 20172053
[TBL] [Abstract][Full Text] [Related]
35. An urn based covariate adjusted response adaptive allocation design.
Bandyopadhyay U; Bhattacharya R
Stat Methods Med Res; 2012 Apr; 21(2):135-48. PubMed ID: 22287603
[TBL] [Abstract][Full Text] [Related]
36. Response adaptive designs with a variance-penalized criterion.
Yi Y; Wang X
Biom J; 2009 Oct; 51(5):763-73. PubMed ID: 19757432
[TBL] [Abstract][Full Text] [Related]
37. Bivariate sequential designs for phase II trials.
Conaway MR; Petroni GR
Biometrics; 1995 Jun; 51(2):656-64. PubMed ID: 7662852
[TBL] [Abstract][Full Text] [Related]
38. Response-Adaptive Allocation for Circular Data.
Biswas A; Dutta S; Laha AK; Bakshi PK
J Biopharm Stat; 2015; 25(4):830-42. PubMed ID: 24919034
[TBL] [Abstract][Full Text] [Related]
39. On group sequential designs comparing two binomial proportions.
Kepner JL
J Biopharm Stat; 2010 Jan; 20(1):145-59. PubMed ID: 20077254
[TBL] [Abstract][Full Text] [Related]
40. The use of the triangular test with response-adaptive treatment allocation.
Coad DS; Ivanova A
Stat Med; 2005 May; 24(10):1483-93. PubMed ID: 15706635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
